This study is the first to directly compare the relative effects of duloxetine, escitalopram, and sertraline on the functional activity of the drug-metabolizing cytochrome P450 2D6 enzyme as assessed by changes in the pharmacokinetics of the cytochrome P450 2D6 model substrate drug, metoprolol. Single-dose pharmacokinetics of metoprolol were measured before and after 17 days of treatment with escitalopram 20 mg/d, duloxetine 60 mg/d, or sertraline 100 mg/d in young healthy male and female participants. The outcome measures were changes in metoprolol peak plasma levels, area under the plasma concentration-time curve, and clearance. The results were tested using paired t tests and independent t tests. The addition of each drug produced statistically significant changes in metoprolol pharmacokinetics. The rank order for the change in metoprolol area under the plasma concentration-time curve was duloxetine (180%) > escitalopram (89%) > sertraline (48% and 67%). Compared with sertraline, duloxetine produced statistically significantly larger changes in metoprolol pharmacokinetic parameters. The changes produced by escitalopram and sertraline were not statistically different.
%0 Journal Article
%1 preskorn2007comparison
%A Preskorn, Sheldon H.
%A Greenblatt, David J.
%A Flockhart, David A.
%A Luo, Yan
%A Perloff, Elke S.
%A Harmatz, Jerold S.
%A Baker, Bryan
%A Klick-Davis, Alisa
%A Desta, Zereusenay
%A Burt, Tal
%D 2007
%J Journal of Clinical Psychopharmacology
%K depression genetics gratis medicine pharma psychiatry research
%N 1
%P 28-34
%R 10.1097/00004714-200702000-00005
%T Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers
%U https://www.researchgate.net/publication/6576977_Comparison_of_Duloxetine_Escitalopram_and_Sertraline_Effects_on_Cytochrome_P450_2D6_Function_in_Healthy_Volunteers
%V 27
%X This study is the first to directly compare the relative effects of duloxetine, escitalopram, and sertraline on the functional activity of the drug-metabolizing cytochrome P450 2D6 enzyme as assessed by changes in the pharmacokinetics of the cytochrome P450 2D6 model substrate drug, metoprolol. Single-dose pharmacokinetics of metoprolol were measured before and after 17 days of treatment with escitalopram 20 mg/d, duloxetine 60 mg/d, or sertraline 100 mg/d in young healthy male and female participants. The outcome measures were changes in metoprolol peak plasma levels, area under the plasma concentration-time curve, and clearance. The results were tested using paired t tests and independent t tests. The addition of each drug produced statistically significant changes in metoprolol pharmacokinetics. The rank order for the change in metoprolol area under the plasma concentration-time curve was duloxetine (180%) > escitalopram (89%) > sertraline (48% and 67%). Compared with sertraline, duloxetine produced statistically significantly larger changes in metoprolol pharmacokinetic parameters. The changes produced by escitalopram and sertraline were not statistically different.
@article{preskorn2007comparison,
abstract = {This study is the first to directly compare the relative effects of duloxetine, escitalopram, and sertraline on the functional activity of the drug-metabolizing cytochrome P450 2D6 enzyme as assessed by changes in the pharmacokinetics of the cytochrome P450 2D6 model substrate drug, metoprolol. Single-dose pharmacokinetics of metoprolol were measured before and after 17 days of treatment with escitalopram 20 mg/d, duloxetine 60 mg/d, or sertraline 100 mg/d in young healthy male and female participants. The outcome measures were changes in metoprolol peak plasma levels, area under the plasma concentration-time curve, and clearance. The results were tested using paired t tests and independent t tests. The addition of each drug produced statistically significant changes in metoprolol pharmacokinetics. The rank order for the change in metoprolol area under the plasma concentration-time curve was duloxetine (180%) > escitalopram (89%) > sertraline (48% and 67%). Compared with sertraline, duloxetine produced statistically significantly larger changes in metoprolol pharmacokinetic parameters. The changes produced by escitalopram and sertraline were not statistically different.},
added-at = {2017-02-03T19:05:37.000+0100},
author = {Preskorn, Sheldon H. and Greenblatt, David J. and Flockhart, David A. and Luo, Yan and Perloff, Elke S. and Harmatz, Jerold S. and Baker, Bryan and Klick-Davis, Alisa and Desta, Zereusenay and Burt, Tal},
biburl = {https://www.bibsonomy.org/bibtex/2e7a7069fcbf1f1e75163ca73e536044b/shelley.adams},
doi = {10.1097/00004714-200702000-00005},
interhash = {0c819be7c52883b2cdfec0b932e2eb24},
intrahash = {e7a7069fcbf1f1e75163ca73e536044b},
journal = {Journal of Clinical Psychopharmacology},
keywords = {depression genetics gratis medicine pharma psychiatry research},
month = feb,
number = 1,
pages = {28-34},
pmid = {17224709},
timestamp = {2017-02-03T19:05:37.000+0100},
title = {Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers},
url = {https://www.researchgate.net/publication/6576977_Comparison_of_Duloxetine_Escitalopram_and_Sertraline_Effects_on_Cytochrome_P450_2D6_Function_in_Healthy_Volunteers},
volume = 27,
year = 2007
}